Gracell Biotechnologies Inc. (GRCL)
Market Closed
21 Feb, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
10. 25
+0.01
+0.0488%
$
197.97M Market Cap
- P/E Ratio
- Div Yield
6.37M Volume
- Eps
$ 10.24
Previous Close Investors:
Want to track GRCL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Gracell Biotechnologies Inc. (GRCL) Statistics
Valuation metrics
Market Cap 197.97M
Enterprise value 64.75M
Trailing P/E (ttm) -1.54
Forward P/E -
PEG ratio -0.07
Price/Sales (ttm) -
Price/Book (mrq) 0.68
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.11
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 250
Average volume (90 days) 3.71K
Price summary
52-Week low 1.4
52-Week high 10.44
Beta -
50-Day moving average 574.87
200-Day moving average 459.23
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.37%
Return on equity -0.38%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -44.87
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 107.69
Total debt (mrq) -
Total Debt/Equity (mrq) 0.13
Current ratio (mrq) 6.78%
Book value per share (mrq) 101.61
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
